DNA methylation-based immune profiling reveals distinct subtypes in esophageal adenocarcinoma.
BACKGROUND Only a subset of patients with esophageal adenocarcinoma (EAC) achieve complete or partial histopathological response to immunotherapy, highlighting the need for better understanding of the tumor microenvironment (TME). Despite efforts to characterize the EAC TME at the molecular level, its epigenetic landsc...